Heron Therapeutics, Inc
Financing
SEC filings to 2026-10-05 · every row opens its filingShares on issue
189.9M
on 2026-08-05, from 150.7M on 2024-05-02 10-Q ↗
a raise that quarter, at its price
1 of its filings are not read yet.
Warrants
The 10-Q filed 2026-08-10 is not read yet.
Cash
14.7 quarters
$42.7M on 2026-06-30 ÷ $2.9M a quarter of operating cash used, the average of four quarters. 10-Q ↗
| Date | What | Shares | Price | Gross | Filing |
|---|---|---|---|---|---|
| 2025-08-08 | Private placement | not read | $1.50 | not stated | 8-K ↗ |
Also on file: $150.0M convertible notes, 2025-08-08 8-K ↗